Literature DB >> 9792143

Comparison of benign and malignant follicular thyroid tumours by comparative genomic hybridization.

S Hemmer1, V M Wasenius, S Knuutila, H Joensuu, K Franssila.   

Abstract

DNA copy number changes were compared in 29 histologically benign follicular adenomas, of which five were atypical, and 13 follicular carcinomas of the thyroid by comparative genomic hybridization. DNA copy number changes were frequent in adenomas (14 out of 29, 48%). Most changes were gains, and they always involved a gain of the entire chromosome 7 (10 out of 29, 34%); other common gains involved chromosomes 5 (28%), 9 (10%), 12 (24%), 14 (21%), 17 (17%), 18 (14%) and X (17%). Losses were found only in four (14%) adenomas. Two of the five atypical adenomas had DNA copy number losses, and none had gains. Unlike adenomas, gains were rare and losses were frequent in carcinomas. A loss of chromosome 22 or 22q was particularly common in carcinomas (6 out of 13, 46%), whereas a loss of chromosome 22 was found in only two (7%) adenomas, one of which was atypical (P = 0.002). A loss of 1p was also frequent in carcinomas (31%), but gains of chromosomes 5, 7, 12, 14 or X that were common in adenomas were not found. Loss of chromosome 22 or 22q was present in six of the eight widely invasive follicular carcinomas, but in only one of the five minimally invasive carcinomas. We conclude that large DNA copy number changes are common in thyroid adenomas. These changes are strikingly different from those found in follicular carcinomas consisting of few losses and frequent gains, especially those of chromosome 7. A loss of chromosome 22 is common in widely invasive follicular carcinoma.

Entities:  

Mesh:

Year:  1998        PMID: 9792143      PMCID: PMC2063166          DOI: 10.1038/bjc.1998.620

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Classification and prognosis of thyroid carcinoma. A study of 885 cases observed in a thirty year period.

Authors:  L B WOOLNER; O H BEAHRS; B M BLACK; W M McCONAHEY; F R KEATING
Journal:  Am J Surg       Date:  1961-09       Impact factor: 2.565

2.  Optimization of comparative genomic hybridization using fluorochrome conjugated to dCTP and dUTP nucleotides.

Authors:  W el-Rifai; M L Larramendy; A M Björkqvist; S Hemmer; S Knuutila
Journal:  Lab Invest       Date:  1997-12       Impact factor: 5.662

3.  The WHO histological classification of thyroid tumors: a commentary on the second edition.

Authors:  C Hedinger; E D Williams; L H Sobin
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

4.  Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors.

Authors:  D E Schofield; J B Beckwith; J Sklar
Journal:  Genes Chromosomes Cancer       Date:  1996-01       Impact factor: 5.006

5.  Cytogenetics of thyroid follicular adenomas.

Authors:  E van den Berg; J W Oosterhuis; B de Jong; J Buist; A Vos; A Dam; B Vermeij
Journal:  Cancer Genet Cytogenet       Date:  1990-02

6.  Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers.

Authors:  M A Herrmann; I D Hay; D H Bartelt; S R Ritland; R J Dahl; C S Grant; R B Jenkins
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

7.  Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.

Authors:  M H Ruttledge; J Sarrazin; S Rangaratnam; C M Phelan; E Twist; P Merel; O Delattre; G Thomas; M Nordenskjöld; V P Collins
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

8.  Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.

Authors:  S K Grebe; B McIver; I D Hay; P S Wu; L M Maciel; H A Drabkin; J R Goellner; C S Grant; R B Jenkins; N L Eberhardt
Journal:  J Clin Endocrinol Metab       Date:  1997-11       Impact factor: 5.958

9.  Abnormalities of chromosome 22 in meningiomas and confirmation of the origin of a dicentric 22 by in situ hybridization.

Authors:  V Tonk; P Osella; A Delasmorenas; H E Wyandt; A Milunsky
Journal:  Cancer Genet Cytogenet       Date:  1992-11

10.  Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma.

Authors:  A M Björkqvist; L Tammilehto; S Anttila; K Mattson; S Knuutila
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  10 in total

1.  Tumor heterogeneity in a follicular carcinoma of thyroid: a study by comparative genomic hybridization.

Authors:  Leonard Da Silva; Daniel James; Peter T Simpson; Daniel Walker; Ana Cristina Vargas; Janani Jayanthan; Sunil R Lakhani; Anne Marie McNicol
Journal:  Endocr Pathol       Date:  2011-06       Impact factor: 3.943

2.  Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas.

Authors:  S Hemmer; V M Wasenius; C Haglund; Y Zhu; S Knuutila; K Franssila; H Joensuu
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

3.  Mechanisms underlying losses of heterozygosity in human colorectal cancers.

Authors:  S Thiagalingam; S Laken; J K Willson; S D Markowitz; K W Kinzler; B Vogelstein; C Lengauer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

Review 4.  Follicular, papillary, and "hybrid" carcinomas of the thyroid.

Authors:  Patrícia Castro; Elsa Fonseca; João Magalhães; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

5.  DNA copy number changes in thyroid carcinoma.

Authors:  S Hemmer; V M Wasenius; S Knuutila; K Franssila; H Joensuu
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

6.  Genomic differences in benign and malignant follicular thyroid tumours using 1-Mb array-comparative genomic hybridisation.

Authors:  Abdul A Qureshi; V P Collins; P Jani
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-04-13       Impact factor: 2.503

7.  Evaluation of the PAX8/PPARG translocation in follicular thyroid cancer with a 4-color reverse-transcription PCR assay and automated high-resolution fragment analysis.

Authors:  Alicia Algeciras-Schimnich; Dragana Milosevic; Bryan McIver; Heather Flynn; Honey V Reddi; Norman L Eberhardt; Stefan K G Grebe
Journal:  Clin Chem       Date:  2010-01-07       Impact factor: 8.327

8.  DNA copy number variations characterize benign and malignant thyroid tumors.

Authors:  Yan Liu; Leslie Cope; Wenyue Sun; Yongchun Wang; Nijaguna Prasad; Lauren Sangenario; Kristen Talbot; Helina Somervell; William Westra; Justin Bishop; Joseph Califano; Martha Zeiger; Christopher Umbricht
Journal:  J Clin Endocrinol Metab       Date:  2013-01-23       Impact factor: 5.958

9.  Genetic and biological subgroups of low-stage follicular thyroid cancer.

Authors:  Christopher A French; Erik K Alexander; Edmund S Cibas; Vania Nose; Julia Laguette; William Faquin; Jeff Garber; Francis Moore; Jonathan A Fletcher; P Reed Larsen; Todd G Kroll
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

10.  Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma.

Authors:  Seung-Hyun Jung; Min Sung Kim; Chan Kwon Jung; Hyun-Chun Park; So Youn Kim; Jieying Liu; Ja-Seong Bae; Sung Hak Lee; Tae-Min Kim; Sug Hyung Lee; Yeun-Jun Chung
Journal:  Oncotarget       Date:  2016-10-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.